Intense nonpharmacological intervention in subjects with multiple cardiovascular risk factors: Decreased fasting insulin levels but only a minor effect on plasma plasminogen activator inhibitor activity

Metabolism: Clinical and Experimental

Volumn 47, Issue 4, 1998, Pages 384-390

  Lindahl, B ^a,b   Nilsson, T K ^a   Asplund, K ^a   Hallmans, G ^a  

^a UMEÅ UNIVERSITY   (Sweden)

^b UMEÅ UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; PLASMINOGEN ACTIVATOR INHIBITOR;

ADULT; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; DIET RESTRICTION; DISEASE ASSOCIATION; FEMALE; FIBRINOLYSIS; FOLLOW UP; HIGH FIBER DIET; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR;

EID: 0031891322     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(98)90047-6     Document Type: Article

References (46)

1. Nordöy A: Haemostatic factors in coronary heart disease. J Intern Med 233:377-383, 1993
2. Reaven GM: Banting Lecture 1988. Role of insulin resistance in human disease. Diabetes 37:1595-1607, 1988
3. Modan M, Halkin H, Shlomo A, et al: Hyperinsulinemia. A link between hypertension, obesity and glucose intolerance. J Clin Invest 75:809-817, 1985
4. DeFronzo RA, Ferrannini E: Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dy slipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 14:173-194, 1991
5. Ferrannini E, Natali A: Essential hypertension, metabolic disorders, and insulin resistance. Am Heart J 121:1274-1282, 1991
6. Lindahl B, Asplund K, Hallmans G: High serum insulin, insulin resistance and their associations with cardiovascular risk factors. The Northern Sweden MONICA Population Study. J Intern Med 234:263-270, 1993
7. Juhan-Vague I, Alessi MC, Vague P: Increased plasma plasminogen activator inhibitor 1 levels. A possible link between insulin resistance and atherothrornbosis. Diabetologia 34:457-462, 1991
8. Lindahl B, Asplund K, Eliasson M, et al: Insulin resistance syndrome and fibrinolytic activity: The Northern Sweden MONICA Study. Int J Epidemiol 25:291-299, 1996
9. Hamsten A, Walldius G, Szamosi A, et al: Plasminogen activator inhibitor in plasma: Risk factor for recurrent myocardial infarction. Lancet 2:3-9, 1987
10. Jansson JH, Olofsson BO, Nilsson TK: Predictive value of tissue plasminogen activator mass concentration on long-term mortality in patients with coronary artery disease. A 7-year follow-up. Circulation 88:2030-2034, 1993
11. Ridker PM, Vaughan DE, Stampfer MJ, et al: Endogenous tissue-type plasminogen activator and risk of myocardial infarction. Lancet 341:1165-1168, 1993
12. Ducimetiere P, Eschwege E, Papoz L, et al: Relationship of plasma insulin levels to the incidence of myocardial infarction and coronary heart disease mortality in a middle-aged population. Diabetologia 19:205-210, 1980
13. Pyörälä K, Savoliainen E, Kaukola S, et al: Plasma insulin as coronary heart disease risk factor: Relationship to other risk factors and predicitive value during 91/2-year follow-up of the Helsinki policemen study population. Acta Med Scand Suppl 701:38-52, 1985
14. Speiser W, Langer W, Pschaick A, et al: Increased blood fibrinolytic activity after physical exercise: Comparative study in individuals with different sporting activities and in patients after myocardial infarction taking part in a rehabilitation sports program. Thromb Res 51:543-555, 1988
15. Szymanski LM, Pate RR, Durstine JL: Effects of maximal exercise and venous occlusion on fibrinolytic activity in physically active and inactive men. J Appl Physiol 77:2305-2310, 1994
16. Stratton JR, Chandler WL, Schwartz RS, et al: Effects of physical conditioning on fibrinolytic variables and fibrinogen in young and old healthy adults. Circulation 83:1692-1697, 1991
17. Gris JC, Schved JF, Aguilar-Martinez P, et al: Impact of physical training on plasminogen activator inhibitor activity in sedentary men. Fibrinolysis 4:97-98, 1990 (suppl 2)
18. Boman K, Hellsten G, Brace Å, et al: Endurance physical activity, diet and fibrinolysis. Atherosclerosis 106:65-74, 1994
19. Marckmann P, Sandström B, Jespersen J: Fasting blood coagulation and fibrinolysis of young adults unchanged by reduction in dietary fat content. Arterioscler Thromb 12:201-205, 1992
20. Hellsten G, Boman K, Saarem K, et al: Effects on fibrinolytic activity of corn oil and a fish oil preparation enriched with omega-3-polyunsaturated fatty acids in a long-term study. Curr Med Res Opin 13:133-139, 1993
21. Nilsson TK, Sundell BI, Hellsten G, et al: Reduced plasminogen activator inhibitor activity in high consumers of fruits, vegetables and root vegetables. J Intern Med 227:267-271, 1993
22. Sundell BI, Rånby M: Oat husk fiber decreases plasminogen activator inhibitor type 1 activity. Haemostasis 23:45-51, 1993
23. Marckmann P, Sandström B, Jespersen J: Favorable long-term effect of a low-fat/high-fiber diet on human blood coagulation and fibrinolysis. Arterioscler Thromb 13:505-511, 1993
24. Folsom AR, Qamhieh HT, Wing RR, et al: Impact of weight loss on plasminogen activator inhibitor (PAI-1), factor VII, and other hemostatic factors in moderately overweight adults. Arterioscler Thromb 13:162-169, 1993
25. Sylvan A, Rutegård JN, Janunger KG, et al: Normal plasminogen activator inhibitor levels at long-term follow-up after jejuno-ileal bypass surgery in morbidly obese individuals. Metabolism 41:1370-1372, 1992
26. Primrose JN, Davies JA, Prentice CRM, et al: Reduction of factor VU, fibrinogen and plasminogen activator inhibitor-1 activity after surgical treatment of morbid obesity. Thromb Haemost 68:396-399, 1992
27. Juhan-Vague I, Vague P, Alessi MC, et al: Relationships between plasma insulin, triglycerides, body mass index, and plasminogen activator inhibitor 1. Diabete Metab 13:331-336, 1987
28. Steiner G: Altering triglyceride concentrations changes insulinglucose relationships in liypertriglyceridemic patients. Double-blind study with gemfibrozil with implications for atherosclerosis. Diabetes Care 14:1077-1081, 1991
29. Vague P, Juhan-Vague I, Alessi MC, et al: Metformin decreases the high plasminogen activator inhibition capacity, plasma insulin and triglyceride levels in non-diabetic obese subjects. Thromb Haemost 57:326-328, 1987
30. Veenstra J, te Wierik E, Kluft C: Alcohol and fibrinolysis. Fibrinolysis 4:64-68, 1990 (suppl 2)
31. Åstrand PO: Quantification of exercise capability and evaluation of physical capacity in man. Prog Cardiovasc Dis 19:51-67, 1976
32. Patton JF, Vogel JA, Mello RP: Evaluation of a maximal predictive cycle ergometer test of aerobic power. Eur J Appl Physiol 49:131-140, 1982
33. Arts FJP, Kuipers H, Jeunkendrup AE, et al: A short cycle ergometer test to predict maximal workload and maximal oxygen uptake. Int J Sports Med 14:460-464, 1993
34. Rånby M, Sundell BI, Nilsson TK: Blood collection in strong acidic citrate anticoagulant used in a study of dietary influence on basal tPA activity. Thromb Haemost 62:917-922, 1989
35. Chmielewska J, Wiman B: Determination of tissue plasminogen activator and its "fast" inhibitor from plasma. Clin Chem 32:482-485, 1986
36. Cody RP, Smith JK: Applied Statistics and the SAS Programming Language (ed 3). New York, NY, Elsevier Science, 1991
37. Johansson I, Wikman Å, Hallmans G: Changes in food selection in northern Sweden - The MONICA surveys 1986 and 1990. Scand J Nutr 38:56-61, 1994
38. De Geus EJC, Kluft C, De Bart ACW, et al: Effects of exercise training on plasminogen activator inhibitor activity. Med Sci Sports Exerc 24:1210-1219, 1992
39. Ogston D, McAndrew GM: Fibrinolysis in obesity. Lancet 2:1205-1207, 1964
40. Bahru Y, Kesteven P, Alberti KGMM, et al: Decreased plasminogen activator inhibitor-1 activity in newly diagnosed type 2 diabetic patients following dietary modification. Diabet Med 10:802-806, 1993
41. Humphries SE, Green FR, Temple A, et al: Genetic factors determining thrombosis and fibrinolysis. Ann Epidemiol 2:371-385, 1992
42. Mykkänen L, Rönnemaa T, Marniemi J, et al: Insulin sensitivity is not an independent determinant of plasma plasminogen activator inhibitor-1 activity. Arterioscler Thromb 14:1264-1271, 1994
43. Schneider DJ, Nordt TK, Sobel BE: Stimulation by proinsulin of expression of plasminogen activator inhibitor type 1 in endothelial cells. Diabetes 41:890-895, 1992
44. Klassen KJ, Nordt TK, Schneider DJ, et al: Constitutive biosynthesis of plasminogen activator inhibitor type 1 (PAI-1) by cultured human aortic endothelial cells independent of insulin. Coron Artery Dis 4:713-719, 1993
45. Asplund-Carlson A, Hamsten A, Wiman B, et al: Relationship between plasma plasminogen activator inhibitor-1 activity and VLDL triglyceride concentration, insulin levels and insulin sensitivity: Studies in randomly selected normo- and hypertriglyceridaemic men. Diabetologia 36:817-825, 1993
46. Stiko-Rahm A, Wiman B, Hamsten A, et al: Secretion of plasminogen activator inhibitor-1 from cultured human umbilical vein endothelial cells is induced by very low density lipoprotein. Arteriosclerosis 10:1067-1073, 1990